Data gathered: May 31
AI Stock Analysis - Astria Therapeutics (ATXS)
Analysis generated September 26, 2024. Powered by Chat GPT.
Astria Therapeutics is a biopharmaceutical company dedicated to creating new medicines for rare, debilitating diseases. The company focuses heavily on research and development activities aimed at addressing unmet medical needs. Astria competes in a niche market but is primarily driven by its core competency in innovative treatments and its ability to bring new products to market through clinical trials and regulatory approvals.
Stock Alerts - Astria Therapeutics (ATXS)
 |
Astria Therapeutics | May 30 Price is down by -7.1% in the last 24h. |
|
Astria Therapeutics | May 29 Price is up by 7.6% in the last 24h. |
|
Astria Therapeutics | May 28 Price is up by 7.3% in the last 24h. |
|
Astria Therapeutics | May 21 Price is down by -7.2% in the last 24h. |
Download our app to get future alerts delivered in real-time.
Alternative Data for Astria Therapeutics
| Alternative Data | Value | 3m Change | Trend | Benchmark |
|---|---|---|---|---|
| Sentiment | N/A | Sign up | Sign up | Sign up |
| Webpage traffic | 4,000 | Sign up | Sign up | Sign up |
| Google Trends | N/A | Sign up | Sign up | Sign up |
| 4chan Mentions | N/A | Sign up | Sign up | Sign up |
| Reddit Mentions | N/A | Sign up | Sign up | Sign up |
| Stocktwits Mentions | 3 | Sign up | Sign up | Sign up |
| Stocktwits Subscribers | 11,149 | Sign up | Sign up | Sign up |
| Twitter Mentions | N/A | Sign up | Sign up | Sign up |
| News Mentions | N/A | Sign up | Sign up | Sign up |
| Customer reviews | N/A | Sign up | Sign up | Sign up |
About Astria Therapeutics
None
| Price | $4.76 |
| Target Price | Sign up |
| Volume | 861,510 |
| Market Cap | $279M |
| Year Range | $3.75 - $12.65 |
| Dividend Yield | 0% |
| Analyst Rating | 100% buy |
| Industry | Biotechnology |
In the news
 |
Astria Therapeutics to Present at Upcoming Jefferies Global Healthcare ConferenceMay 27 - Yahoo |
 |
Janus Henderson Group PLC Purchases Shares of 17,700 Astria Therapeutics, Inc. (NASDAQ:ATXS)May 26 - ETF Daily News |
|
Brokerages Set Astria Therapeutics, Inc. (NASDAQ:ATXS) Price Target at $30.00May 23 - ETF Daily News |
|
Astria Therapeutics to Present at Upcoming C1 Inhibitor Deficiency and Angioedema WorkshopMay 22 - Yahoo |
|
Astria Therapeutics to Present at Upcoming Eastern Allergy ConferenceMay 21 - Yahoo |
|
Cubist Systematic Strategies LLC Invests $137,000 in Astria Therapeutics, Inc. (NASDAQ:ATXS)May 19 - ETF Daily News |
Financial performance View All
| Revenue | Cost of Revenue | Gross Profit | Net Income | ebitda | EPS | |
|---|---|---|---|---|---|---|
| Q1 '25 | 0 | 0 | 0 | -34M | -37M | -0.580 |
| Q4 '24 | 0 | 0 | 0 | -26M | -30M | -0.440 |
| Q3 '24 | 0 | 0 | 0 | -25M | -29M | -0.420 |
| Q2 '24 | 0 | 0 | 0 | -24M | -29M | -0.430 |
| Q1 '24 | 0 | 0 | 0 | -20M | -24M | -0.380 |
Insider Transactions View All
| EDELMAN JOSEPH filed to buy 4,873,721 shares at $12.1. February 5 '24 |
| EDELMAN JOSEPH filed to buy 2,392,371 shares at $6.2. December 22 '23 |
Similar companies
Read more about Astria Therapeutics (ATXS) and their ai stock analysis, price prediction, earnings, congress trading, insider transactions, technical analysis, sentiment, webpage traffic, google trends, 4chan mentions, reddit mentions, stocktwits mentions, stocktwits subscribers, twitter mentions, news mentions & customer reviews.
What is the Market Cap of Astria Therapeutics?
The Market Cap of Astria Therapeutics is $279M.
What is the current stock price of Astria Therapeutics?
Currently, the price of one share of Astria Therapeutics stock is $4.76.
How can I analyze the ATXS stock price chart for investment decisions?
The ATXS stock price chart above provides a comprehensive visual representation of Astria Therapeutics' stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling Astria Therapeutics shares. Our platform offers an up-to-date ATXS stock price chart, along with technical data analysis and alternative data insights.
Does ATXS offer dividends to its shareholders?
As of our latest update, Astria Therapeutics (ATXS) does not offer dividends to its shareholders. Investors interested in Astria Therapeutics should consider the potential for capital appreciation as the primary return on investment, rather than expecting dividend payouts.
What are some of the similar stocks of Astria Therapeutics?
Some of the similar stocks of Astria Therapeutics are Amgen, Gilead Sciences, Catalyst Pharmaceuticals, Inovio Pharmaceuticals, and Anavex Life Sciences.
.